Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyrica for anxiety in partial epilepsy
NCT01128712Phase 4Terminated
- Sponsor
- Northeast Regional Epilepsy Group
- Start
- Apr 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregabalin in anxiety disorder, sponsored by Northeast Regional Epilepsy Group. Started Apr 2010; status: terminated.
02
Drugs
pregabalin
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT01128712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128712.